Vermilion Therapeutics
Akasaka
About Vermilion Therapeutics
Vermilion Therapeutics is a research services center. They provide services for alzheimer's disease, renal amyloidosis, coronavirus infection, and cancer. An online inquiry form is available on the company's website.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Dec 2020)
- Website: vermilion-tx.com
- Phone: 03-3478-2212
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/vermilion-therapeutics-3300332 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.